Results 21 to 30 of about 6,672 (205)

A case of nasopharyngeal angiofibroma removed using a minimally invasive endoscopic endonasal technique

open access: yesVideosurgery and Other Miniinvasive Techniques, 2018
Nasopharyngeal angiofibroma is a rare head and neck tumor characterized by hypervascularity. With the development of various surgical devices and hemostatic agents, endoscopic endonasal surgery for nasopharyngeal angiofibroma, which is characterized by ...
Ji Sun Kim   +3 more
doaj   +1 more source

Recurrent Angiofibroma of Ethmoid Region – A Rare Variant [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2014
The common variant of angiofibromas of head and neck region is juvenile nasopharyngeal angiofibroma (JNA). However extranasopharyngeal angiofibromas (ENAF) occurs very rarely at any age in either sex, and they differ from classical JNA in incidence ...
M. SUDHAKARA RAO   +4 more
doaj   +1 more source

Risk Factors and Characteristics of the Recurrence of Juvenile Nasopharyngeal Angiofibroma: A 22-Year Experience With 123 Cases at a Tertiary Center [PDF]

open access: yesClinical and Experimental Otorhinolaryngology, 2022
Objectives. Despite the efficacy of surgical treatments, the high rate of recurrence in juvenile nasopharyngeal angiofibroma (JNA) after surgery remains an unresolved problem.
Ruihua Fang   +9 more
doaj   +1 more source

Rhinophyma in tuberous sclerosis complex: case report with brief review of literature

open access: yesGMS Interdisciplinary Plastic and Reconstructive Surgery DGPW, 2014
Tuberous sclerosis or tuberous sclerosis complex (TSC) is an autosomal dominant inherited disease characterized by the triad epilepsy, hamartomas (angiofibroma) and reduced intellectual capacity. Phenotype can vary considerably.
Friedrich, Reinhard E., Hagel, Christian
doaj   +1 more source

Juvenile angiofibroma: etiology, diagnosis, treatment

open access: yesJournal of Education, Health and Sport, 2020
Introduction and purpose: Juvenile angiofibroma is a rare neoplasm of the nasopharynx. It occurs almost exclusively in boys during adolescence. It is a richly vascularized neoplasm which, despite its benign histopathological character, tends to invasive ...
Madalena Marzęda   +3 more
doaj   +1 more source

Extranasopharyngeal Angiofibroma of the Nasal Septum: A Case Report

open access: yes대한영상의학회지, 2019
Angiofibroma is benign hypervascular tumor that usually occurs in the nasopharynx of adolescent male patient and rarely originates from outside of the nasopharynx, called extranasopharyngeal angiofibroma.
Gyoung-Eun Lee   +7 more
doaj   +1 more source

Extranasopharyngeal Angiofibroma Originating in the Inferior Turbinate: A Distinct Clinical Entity at an Unusual Site

open access: yesInternational Archives of Otorhinolaryngology, 2014
Introduction The extranasopharyngeal angiofibroma is histologically similar to juvenile nasopharyngeal angiofibroma, differing from the latter in clinical and epidemiologic characteristics. Objectives We present a case of extranasopharyngeal
Marco Antonio Ferraz de Barros Baptista   +2 more
doaj   +1 more source

Cellular angiofibroma in women: A review of the literature [PDF]

open access: yes, 2015
Cellular Angiofibroma (CA) represents a quite recently described mesenchymal tumour that occurs in both genders, in particular in the vulvo-vaginal region in women and in the inguino-scrotal area in men.
Abrate, Martino   +5 more
core   +1 more source

Nasal Septal Angiofibroma [PDF]

open access: yesEar, Nose & Throat Journal, 2021
Juvenile nasopharyngeal angiofibroma is a benign vascular tumor seen predominantly in adolescent males in the second decade of life. Extranasopharyngeal angiofibroma includes vascular fibrous masses that occur outside the nasopharynx. The diagnosis of an angiofibroma is based on the clinical presentation and imaging, with biopsies being avoided to ...
Oratile Thobejane, Shivesh Maharaj
openaire   +2 more sources

Efficacy and Safety of Topical Mechanistic Target of Rapamycin Inhibitors for Facial Angiofibromas in Patients with Tuberous Sclerosis Complex: A Systematic Review and Network Meta-Analysis

open access: yesBiomedicines, 2022
Previous studies have suggested that the topical mechanistic target of rapamycin (mTOR) inhibitors may be effective in treating facial angiofibromas in patients with tuberous sclerosis complex (TSC).
Yu-Ting Lin   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy